Translational Breast Cancer Research Consortium (TBCRC) 022: A Phase II Trial of Neratinib for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases.
暂无分享，去创建一个
E. Winer | K. Hess | Minetta C. Liu | N. Ibrahim | R. Gelman | K. Blackwell | A. Wolff | N. Lin | N. Agar | B. Moy | M. Melisko | A. Lowe | S. Puhalla | C. V. Van Poznak | I. Krop | J. Wefel | R. Connolly | R. Freedman | M. Rimawi | P. Niravath | E. Lawler | C. Herold | N. Ryabin | S. Farooq | Sarah Farooq